
David Flacks
David Flacks is the chairman of AFT Pharmaceuticals, a role he has held for 11 years, during which he has overseen significant growth in the company's revenues from $56.2 million in 2015 to $254.7 million. He recently announced his plans to retire within the next 12 months.
Power189
Reach4,337
Country presence
Recent news mentions
AFT Pharmaceuticals announced its chairman, David Flacks, was retiring within the next 12 months.
NZ sharemarket ends week down 0.4% – Market closeThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2026-07-31

